Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2009 - 2026)

Vertex Pharmaceuticals' Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 1.48% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (down 1.48% YoY), while the FY2025 annual figure was $1.5 billion, down 20.99% from the prior year.
• Goodwill & Intangibles was $1.5 billion for Q1 2026 at Vertex Pharmaceuticals, roughly flat from $1.5 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $1.9 billion in Q4 2023 to a low of $1.4 billion in Q2 2022.
• Historically, Goodwill & Intangibles has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles climbed 21.77% in 2023, then decreased 20.99% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $1.7 billion in 2022, then advanced by 13.17% to $1.9 billion in 2023, then fell by 0.73% to $1.9 billion in 2024, then fell by 20.99% to $1.5 billion in 2025, then slipped by 0.38% to $1.5 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.